Developer docs
API playgroundTry for free, no card

Search company profiles

Diagnostic Solutions Laboratory

Full company profile

uuid000ejxs

Namestring
Diagnostic Solutions Laboratory
Legal namestring
Diagnostic Solutions Lab, LLC
Company typeenum
Private
Founded yearint
2015
Descriptiontext

Diagnostic Solutions Laboratory is a US-based clinical diagnostic laboratory founded in 2015 and headquartered in Alpharetta, Georgia, operating as a private LLC under CEO Tony Hoffman. The company specializes in advanced gastrointestinal and functional medicine testing, built around a quantitative PCR (qPCR) platform that detects and quantifies microbial DNA from stool samples — it self-describes as the only US laboratory exclusively using qPCR for comprehensive stool testing. Its flagship product, the GI-MAP (Gastrointestinal Microbial Assay Plus), is supported by a growing add-on ecosystem including StoolOMX (bile acids and short chain fatty acids), Zonulin (intestinal permeability), Fecal Gluten Peptide, and a Universal Antibiotic Resistance Genes Panel covering 55 resistance genes across 10 antibiotic classes. Complementary products include the CytoDx cytokine response profile (40 cytokines), OMX and OAp organic acids/metabolomics panels, IgG and IgE food/allergy panels, a Fatty Acids Profile, GenomicInsight, a Histamine Clearance Index, and a stool Pathogens Panel. Test turnaround on the GI-MAP is 7-10 business days.

The company sells exclusively through licensed healthcare practitioners (NDs, DOs, MDs, PAs, NPs) primarily in the functional and integrative medicine space, with order entry via an online Practitioner Portal, phone, or email and drop-ship capability directly to patients for qualified tests. Only the GI-MAP and GI-MAP with Zonulin are insurance-billable; the remaining menu is cash-pay with discounted self-pay pricing and a deposit requirement at submission. Geographic coverage is concentrated in the US and Canada, with New York state excluded due to licensure. The company reinforces clinical adoption through DSL Academy, a gated education platform that offers structured courses and a Medical Education Team, plus an extensive content marketing operation (164+ GI-MAP resources including webinars, white papers, and case studies) and active presence at industry events such as IFM APM GI, IDS Integrative Dermatology Symposium, and A4M Longevity Fest. The business is bootstrapped with no disclosed external institutional investment.

Short descriptiontext

Diagnostic Solutions Laboratory is a US-based specialty diagnostic laboratory that uses quantitative PCR technology to deliver comprehensive stool, cytokine, metabolomics, and food sensitivity testing to licensed functional and integrative medicine practitioners.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersAlpharetta, United States
HQ citystring
Alpharetta
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical diagnostic testing, qPCR stool analysis, functional medicine laboratory, cytokine response profiling, microbiome diagnostic tests
Industry4 codes
1HLAGADAF
CodeHLAGADAFPrimaryYes
2HLAAAFAH
CodeHLAAAFAHPrimaryNo
3HLAAALAA
CodeHLAAALAAPrimaryNo
4HLAFAMAD
CodeHLAFAMADPrimaryNo
NAICS code1 code
  • 621511
SIC code1 code
  • 8071
Product category
Clinical Diagnostic Laboratory Services
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Clinical Laboratory Testing Services
TypeOne Time License
Description

Diagnostic laboratory testing services for healthcare practitioners. Tests include GI-MAP, CytoDx, StoolOMX, OMX Organic Metabolomics, OAp Organic Acids Profile, IgG Food Explorer, GenomicInsight, and others. Revenue generated through test fees billed to patients/practitioners.

diagnosticsolutionslab.com
2Insurance Billing
TypeTransaction Fee
Description

Laboratory bills insurance companies directly for qualifying tests. Only GI-MAP and GI-MAP with Zonulin are submitted to insurance; all other testing is cash-only. Medicare participation for traditional Medicare. Out-of-network with commercial insurance.

diagnosticsolutionslab.com
3Cash Pay/ Self-Pay
TypeOne Time License
Description

Direct patient payment for testing services. Discounted cash pricing available. Deposit required at time of test submission (except Medicare). Payment via check, money order, or major credit card.

diagnosticsolutionslab.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Supply Chain
Pricing details3 tiers
1GI-MAP and GI-MAP with Zonulin - Insurance Billable Tests
ModelTransaction based/ take rateBilling cadencePay-as-you-go
Notes

These tests can be billed to insurance (including Medicare for qualifying providers). Claims submitted at regular list price. Patient responsible for deductible, co-pay, co-insurance, and non-covered services.

diagnosticsolutionslab.com
2All Other Tests - Cash Only
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

All other testing (CytoDx, StoolOMX add-ons, OMX, OAp, IgG Food Explorer, etc.) is cash-only. Discounted cash pricing available. Deposit required at time of test submission.

diagnosticsolutionslab.com
3Account Setup - Free
ModelFreemiumBilling cadencePay-as-you-go
Notes

Setting up an account with Diagnostic Solutions Laboratory is free. Collection kits are provided at no charge.

diagnosticsolutionslab.com
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 8 records shown
1GI-MAP
Description

Gastrointestinal Microbial Assay Plus - Comprehensive DNA stool analysis using qPCR technology

diagnosticsolutionslab.com
+7 more records
Core offering1 text field

Diagnostic Solutions Laboratory operates a clinical diagnostic laboratory that performs advanced molecular and functional medicine testing for licensed healthcare practitioners. Its flagship GI-MAP stool test uses proprietary quantitative PCR (qPCR) technology to detect and quantify microbial DNA, complemented by cytokine, metabolomic, food sensitivity, and genomic panels that practitioners order to support personalized treatment protocols for gut, immune, and metabolic conditions.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • GI-MAP can detect H. pylori as low as 100 copies of DNA per gram of stool, while metagenomic sequencing typically requires 100,000-10,000,000 cells
+3 more records
Product overview1 text field

Diagnostic Solutions Laboratory offers a comprehensive portfolio of clinical diagnostic tests primarily focused on functional and integrative medicine. The core products include the GI-MAP (comprehensive stool analysis via qPCR technology) and CytoDx (cytokine response profile for immune function). The product architecture follows a platform-plus-modules model where the GI-MAP serves as the primary platform with multiple add-on panels including StoolOMX (bile acids and SCFAs), Zonulin, Fecal Gluten Peptide, and Universal Antibiotic Resistance Genes. Additional standalone products include OMX (Organic Metabolomics), OAp (Organic Acids Profile), IgG Food Explorer, IgE Allergy Explorer, FAp (Fatty Acids Profile), and Histamine Clearance Index. The company also provides practitioner education through DSL Academy. Tests are ordered through licensed healthcare providers and results delivered via the Practitioner Portal.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Genova Diagnostics is the dominant US functional medicine lab offering GI Effects (a comprehensive stool analysis directly comparable to GI-MAP) as well as organic acids, hormones, and genomic tests ordered through licensed practitioners - the same practitioner-led, multi-modality model DSL competes in.

TypeDirect peer
Description

Cyrex Labs sells Array-based food sensitivity, intestinal permeability (zonulin), and autoimmune panels ordered through functional and integrative practitioners - competing head-to-head with DSL's IgG Food Explorer and the GI-MAP Zonulin add-on.

TypeBroad incumbent
Description

Labcorp is a national reference lab that processes conventional stool and parasitology testing for hospitals and physician offices and increasingly offers specialty panels; its payer reach and specimen logistics threaten DSL on the insurance-billable side of the menu.

TypeBroad incumbent
Description

Quest Diagnostics is a national reference lab whose broad portfolio includes conventional stool culture and an expanding menu of specialty/functional assays; its scale and in-network payer contracts pressure niche labs like DSL on insurance-billable commodity stool testing.

TypeDirect peer
Description

Precision Analytical's DUTCH dried-urine hormone/metabolite panels are ordered by the same functional/integrative clinician base via similar drop-ship and portal workflows, competing for the multi-modality upsell dollars DSL targets.

TypeDirect peer
Description

Vibrant Wellness uses multiplex and qPCR-style chemistries to deliver food sensitivity, gut microbiome, and hormone tests through the same practitioner-channel model, directly contesting DSL's qPCR-based functional testing positioning.

TypeDirect peer
Description

ZRT Laboratory sells dried-blood-spot and saliva hormone/metabolite tests through functional medicine providers, with overlapping clinician-only ordering, drop-ship kit, and add-on panel model that complements DSL's diagnostics portfolio.

TypeDirect peer
Description

Doctor's Data has long offered comprehensive stool parasitology, culture-based microbiology, and toxic-element testing ordered through integrative and functional medicine practitioners, overlapping directly with DSL's clinician-channel stool testing focus.

TypeDirect peer
Description

Mosaic Diagnostics serves the same functional medicine prescriber base with Organic Acids Test (OAT), GPL-TOX, and stool-based profiles, providing nearly identical collection-and-drop-ship workflows and clinician-targeted education platforms.

TypeDirect peer
Description

US BioTek provides IgG and IgE food sensitivity panels (160+ antigens) ordered through integrative practitioners, directly competing with DSL's IgG Food Explorer (283 antigens) for the same clinician-driven food sensitivity wallet share.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Diagnostic Solutions Laboratory

Clinical Diagnostic Laboratory Servicesdiagnosticsolutionslab.com

Diagnostic Solutions Laboratory is a US-based specialty diagnostic laboratory that uses quantitative PCR technology to deliver comprehensive stool, cytokine, metabolomics, and food sensitivity testing to licensed functional and integrative medicine practitioners.

What Diagnostic Solutions Laboratory does

Diagnostic Solutions Laboratory is a US-based clinical diagnostic laboratory founded in 2015 and headquartered in Alpharetta, Georgia, operating as a private LLC under CEO Tony Hoffman. The company specializes in advanced gastrointestinal and functional medicine testing, built around a quantitative PCR (qPCR) platform that detects and quantifies microbial DNA from stool samples — it self-describes as the only US laboratory exclusively using qPCR for comprehensive stool testing. Its flagship product, the GI-MAP (Gastrointestinal Microbial Assay Plus), is supported by a growing add-on ecosystem including StoolOMX (bile acids and short chain fatty acids), Zonulin (intestinal permeability), Fecal Gluten Peptide, and a Universal Antibiotic Resistance Genes Panel covering 55 resistance genes across 10 antibiotic classes. Complementary products include the CytoDx cytokine response profile (40 cytokines), OMX and OAp organic acids/metabolomics panels, IgG and IgE food/allergy panels, a Fatty Acids Profile, GenomicInsight, a Histamine Clearance Index, and a stool Pathogens Panel. Test turnaround on the GI-MAP is 7-10 business days.

The company sells exclusively through licensed healthcare practitioners (NDs, DOs, MDs, PAs, NPs) primarily in the functional and integrative medicine space, with order entry via an online Practitioner Portal, phone, or email and drop-ship capability directly to patients for qualified tests. Only the GI-MAP and GI-MAP with Zonulin are insurance-billable; the remaining menu is cash-pay with discounted self-pay pricing and a deposit requirement at submission. Geographic coverage is concentrated in the US and Canada, with New York state excluded due to licensure. The company reinforces clinical adoption through DSL Academy, a gated education platform that offers structured courses and a Medical Education Team, plus an extensive content marketing operation (164+ GI-MAP resources including webinars, white papers, and case studies) and active presence at industry events such as IFM APM GI, IDS Integrative Dermatology Symposium, and A4M Longevity Fest. The business is bootstrapped with no disclosed external institutional investment.

Diagnostic Solutions Laboratory firmographics

Firmographics
Name
Diagnostic Solutions Laboratory
Legal name
Diagnostic Solutions Lab, LLC
Website
https://diagnosticsolutionslab.com
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
11–50 employees
Short description
Diagnostic Solutions Laboratory is a US-based specialty diagnostic laboratory that uses quantitative PCR technology to deliver comprehensive stool, cytokine, metabolomics, and food sensitivity testing to licensed functional and integrative medicine practitioners.
Ownership category
akta.pro rank

Where Diagnostic Solutions Laboratory is headquartered

Location

Headquarters

HQ city
Alpharetta
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Diagnostic Solutions Laboratory business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Supply Chain

Revenue model

  1. Clinical Laboratory Testing Services: Diagnostic laboratory testing services for healthcare practitioners. Tests include GI-MAP, CytoDx, StoolOMX, OMX Organic Metabolomics, OAp Organic Acids Profile, IgG Food Explorer, GenomicInsight, and others. Revenue generated through test fees billed to patients/practitioners.
  2. Insurance Billing: Laboratory bills insurance companies directly for qualifying tests. Only GI-MAP and GI-MAP with Zonulin are submitted to insurance; all other testing is cash-only. Medicare participation for traditional Medicare. Out-of-network with commercial insurance.
  3. Cash Pay/ Self-Pay: Direct patient payment for testing services. Discounted cash pricing available. Deposit required at time of test submission (except Medicare). Payment via check, money order, or major credit card.

Pricing tiers

ModelBillingPrice
Transaction based/ take ratePay-as-you-goGI-MAP and GI-MAP with Zonulin - Insurance Billable Tests
One time/ perpetual licensePay-as-you-goAll Other Tests - Cash Only
FreemiumPay-as-you-goAccount Setup - Free

Go-to-market motion3 records

Distribution channels4 records

Marketing channels7 records

Diagnostic Solutions Laboratory product offering

Product offering

Core offering

Diagnostic Solutions Laboratory operates a clinical diagnostic laboratory that performs advanced molecular and functional medicine testing for licensed healthcare practitioners. Its flagship GI-MAP stool test uses proprietary quantitative PCR (qPCR) technology to detect and quantify microbial DNA, complemented by cytokine, metabolomic, food sensitivity, and genomic panels that practitioners order to support personalized treatment protocols for gut, immune, and metabolic conditions.

Product overview

Diagnostic Solutions Laboratory offers a comprehensive portfolio of clinical diagnostic tests primarily focused on functional and integrative medicine. The core products include the GI-MAP (comprehensive stool analysis via qPCR technology) and CytoDx (cytokine response profile for immune function). The product architecture follows a platform-plus-modules model where the GI-MAP serves as the primary platform with multiple add-on panels including StoolOMX (bile acids and SCFAs), Zonulin, Fecal Gluten Peptide, and Universal Antibiotic Resistance Genes. Additional standalone products include OMX (Organic Metabolomics), OAp (Organic Acids Profile), IgG Food Explorer, IgE Allergy Explorer, FAp (Fatty Acids Profile), and Histamine Clearance Index. The company also provides practitioner education through DSL Academy. Tests are ordered through licensed healthcare providers and results delivered via the Practitioner Portal.

Differentiator

Problem solved

Functional benefit

Brands

  • GI-MAP: Gastrointestinal Microbial Assay Plus - Comprehensive DNA stool analysis using qPCR technology
  • DSL Academy
  • CytoDx
  • StoolOMX
  • IgG Food Explorer
  • OAp - Organic Acids Profile
  • FAp - Fatty Acids Profile
  • Histamine Clearance Index

Quantifiable outcome

  • GI-MAP can detect H. pylori as low as 100 copies of DNA per gram of stool, while metagenomic sequencing typically requires 100,000-10,000,000 cells
  • +3 more outcomes

Companies that use Diagnostic Solutions Laboratory

Customer profile

Named customers6 records

Segments4 records

Ideal customer profiles2 records

Diagnostic Solutions Laboratory technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Diagnostic Solutions Laboratory partnerships and signals

Strategic signal

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Diagnostic Solutions Laboratory competitors and assessment

Company assessment

Direct peers

  • Genova Diagnostics: Genova Diagnostics is the dominant US functional medicine lab offering GI Effects (a comprehensive stool analysis directly comparable to GI-MAP) as well as organic acids, hormones, and genomic tests ordered through licensed practitioners - the same practitioner-led, multi-modality model DSL competes in.
  • Cyrex Labs: Cyrex Labs sells Array-based food sensitivity, intestinal permeability (zonulin), and autoimmune panels ordered through functional and integrative practitioners - competing head-to-head with DSL's IgG Food Explorer and the GI-MAP Zonulin add-on.
  • Precision Analytical (DUTCH): Precision Analytical's DUTCH dried-urine hormone/metabolite panels are ordered by the same functional/integrative clinician base via similar drop-ship and portal workflows, competing for the multi-modality upsell dollars DSL targets.
  • Vibrant Wellness: Vibrant Wellness uses multiplex and qPCR-style chemistries to deliver food sensitivity, gut microbiome, and hormone tests through the same practitioner-channel model, directly contesting DSL's qPCR-based functional testing positioning.
  • ZRT Laboratory: ZRT Laboratory sells dried-blood-spot and saliva hormone/metabolite tests through functional medicine providers, with overlapping clinician-only ordering, drop-ship kit, and add-on panel model that complements DSL's diagnostics portfolio.
  • Doctor's Data: Doctor's Data has long offered comprehensive stool parasitology, culture-based microbiology, and toxic-element testing ordered through integrative and functional medicine practitioners, overlapping directly with DSL's clinician-channel stool testing focus.
  • Mosaic Diagnostics (formerly Great Plains Laboratory): Mosaic Diagnostics serves the same functional medicine prescriber base with Organic Acids Test (OAT), GPL-TOX, and stool-based profiles, providing nearly identical collection-and-drop-ship workflows and clinician-targeted education platforms.
  • US BioTek: US BioTek provides IgG and IgE food sensitivity panels (160+ antigens) ordered through integrative practitioners, directly competing with DSL's IgG Food Explorer (283 antigens) for the same clinician-driven food sensitivity wallet share.

Broad incumbents

  • Labcorp: Labcorp is a national reference lab that processes conventional stool and parasitology testing for hospitals and physician offices and increasingly offers specialty panels; its payer reach and specimen logistics threaten DSL on the insurance-billable side of the menu.
  • Quest Diagnostics: Quest Diagnostics is a national reference lab whose broad portfolio includes conventional stool culture and an expanding menu of specialty/functional assays; its scale and in-network payer contracts pressure niche labs like DSL on insurance-billable commodity stool testing.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Diagnostic Solutions Laboratory social profiles

Digital presence

Diagnostic Solutions Laboratory financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Diagnostic Solutions Laboratory leadership team

Management profile

Number of profiles

Profiles1 record

Diagnostic Solutions Laboratory funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Diagnostic Solutions Laboratory M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Diagnostic Solutions Laboratory

What does Diagnostic Solutions Laboratory do?

Diagnostic Solutions Laboratory operates a clinical diagnostic laboratory that performs advanced molecular and functional medicine testing for licensed healthcare practitioners. Its flagship GI-MAP stool test uses proprietary quantitative PCR (qPCR) technology to detect and quantify microbial DNA, complemented by cytokine, metabolomic, food sensitivity, and genomic panels that practitioners order to support personalized treatment protocols for gut, immune, and metabolic conditions.

Is Diagnostic Solutions Laboratory a public or private company?

Diagnostic Solutions Laboratory is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Diagnostic Solutions Laboratory founded?

Diagnostic Solutions Laboratory was founded in 2015. It employs 11 to 50 people.

Where is Diagnostic Solutions Laboratory based?

Diagnostic Solutions Laboratory is headquartered in Alpharetta, United States, in the North America region.

How does Diagnostic Solutions Laboratory make money?

Three revenue lines are on record. Clinical Laboratory Testing Services are the primary driver. The others are insurance Billing and cash Pay/ Self-Pay.

Who are Diagnostic Solutions Laboratory's main competitors?

Direct peers on record are Genova Diagnostics, Cyrex Labs, Precision Analytical (DUTCH), Vibrant Wellness, ZRT Laboratory, Doctor's Data, Mosaic Diagnostics (formerly Great Plains Laboratory) and US BioTek. Broad incumbents are Labcorp and Quest Diagnostics.

Does Diagnostic Solutions Laboratory have an API?

No public API is recorded for Diagnostic Solutions Laboratory.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
EIN PresswireImmundiagnostik, Inc. and Diagnostic Solutions Laboratory to Highlight Fecal Gluten Peptide Testing at DDW 2026Immundiagnostik, Inc. and Diagnostic Solutions Laboratory will exhibit together at DDW 2026 in Chicago to highlight quantitative fecal gluten peptide testing. The test detects gluten immunogenic peptides in stool, offering an objective measure of recent gluten exposure for monitoring gluten-free diet adherence in celiac disease and non-celiac gluten sensitivity.PR NewswireDiagnostic Solutions Laboratory Launches New OMX™ Organic Metabolomics TestDiagnostic Solutions Laboratory launched its new OMX™ Organic Metabolomics Test, a diagnostic tool that combines organic and amino acid metabolites into a single report to assess patients' metabolic function and reveal their unique 'Metabolic Signature.' The test uses a systems-biology approach, categorizing insights into six areas of functional health including metabolic processing, amino acid metabolism, nutrition, stress and mood, microbial metabolites, and toxic impacts. The OMX test is collected using first morning urine void with optional plasma collection and is designed to help practitioners formulate nutraceutical, dietary, environmental, and lifestyle changes to address dysfunctional metabolic pathways.PR NewswireCoronavirus (COVID-19) Update: Daily RoundupThe FDA and FTC jointly issued warning letters to Hong Kong-based SuperHealthGuard and Loyal Great International, Ltd., ordering them to cease selling unapproved COVID-19 products with misleading therapeutic claims to U.S. consumers, with failure to comply risking legal action including seizure and injunction. The FDA simultaneously expanded its COVID-19 response by issuing Emergency Use Authorizations for additional diagnostic tests from Inform Diagnostics and Diagnostic Solutions Laboratory, and authorizing new ventilators from Stewart & Stevenson Healthcare Technologies and SAGICO USA. To date, the FDA has authorized 155 tests under EUAs, comprising 130 molecular tests, 24 antibody tests, and 1 antigen test.PR NewswireDiagnostic Solutions Laboratory Introduces Test for Rapid COVID-19 DetectionDiagnostic Solutions Laboratory, a CLIA-certified molecular microbiology testing laboratory in Alpharetta, Georgia, has developed a rapid COVID-19 assay test that detects the SARS-CoV-2 virus using RT-PCR technology with a 24-hour turnaround time. The test has been submitted to the FDA under Emergency Use Authorization and is being offered directly to hospitals and healthcare institutions to expand testing capacity during the public health crisis. The laboratory states it has a large supply of reagents and testing materials prepared for high-volume testing.PR NewswireDiagnostic Solutions Laboratory Revolutionizes Precision Medicine with GenomicInsight™ Genomic Health Profile Powered by Opus23 Explorer™Diagnostic Solutions Laboratory announced the launch of GenomicInsight, its first DNA SNP test powered by Opus23 Explorer software, on February 21, 2019. The product analyzes nearly one million single nucleotide polymorphisms and reports on over 5,200 SNPs across more than a dozen areas of patient health, including detoxification, cardiovascular health, methylation, and pharmacogenomics. The Opus23 Explorer software, developed by Dr. Peter D'Adamo of the University of Bridgeport, synthesizes genetic data into an interactive dashboard that provides evidence-based therapeutic recommendations for personalized medicine.